The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Predictors of survival in systemic sclerosis (Scleroderma)
Abstract
We conducted followup of 264 patients with definite systemic sclerosis (SSc) who were entered into the multicenter Scleroderma Criteria Cooperative Study (SCCS) during 1973–1977. At the end of the study (average 5.2 years of followup), 38% were known to be alive, 50% were dead (68% of these deaths definitely related to SSc), and 12% were lost to followup. Survival analyses of 484 demographic, clinical, and laboratory items recorded at entry into the SCCS (within 2 years of physician diagnosis of SSc) were performed. Survival declined linearly, and the cumulative survival rate was <80% at 2 years, 50% at 8.5 years, and 30% at 12 years after entry. Analysis using combinations of entry variables identifying organ system involvement confirmed that renal, cardiac, pulmonary, and gastrointestinal involvement in SSc predicted reduced survival; however, data on organ system involvement at study entry could not be used to consistently predict which organ system would ultimately be involved as the primary cause of death. By survival tree analysis, the individual entry variables best predicting reduced survival included older age (>64 years), reduced renal function (blood urea nitrogen >16 mg/dl), anemia (hemoglobin ≤11 gm/dl), reduced pulmonary diffusing capacity for carbon monoxide (≤50% of predicted), reduced total serum protein level (≤6 gm/dl), and reduced pulmonary reserve (forced vital capacity <80% with hemoglobin >14 gm/dl or forced vital capacity <65% with hemoglobin ≤14 gm/dl). Cox proportional hazards model analysis confirmed these results. Different combinations of variables led to markedly different survival rates. The poorest prospects for survival were in patients with SSc who were ≤64 years old with a hemoglobin level ≤11 gm/dl, and in those >64 years old with a blood urea nitrogen level >16 mg/dl. These results may be useful in predicting individual patients at risk for shortened survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Masi, A. T., & Subcommittee For Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230510 · Cited by 4,898
Steen, V. D., Powell, D. L., & Medsger, T. A. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310207 · Cited by 573
Self-citationDiversity of antinuclear antibodies in progressive systemic sclerosis
Tan, E. M., Rodnan, G. P., Garcia, I., Moroi, Y., Fritzler, M. J., & Peebles, C. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230602 · Cited by 524
Regression Trees for Censored Data
Segal, M. R. (1988) · Biometrics · doi:10.2307/2531894 · Cited by 495
MEDSGER, T. A., MASI, A. T., RODNAN, G. P., BENEDEK, T. G., & ROBINSON, H. (1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-75-3-369 · Cited by 321
Self-citationEpidemiology of Systemic Sclerosis (Scleroderma)
MEDSGER, T. A., & MASI, A. T. (1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-5-714 · Cited by 275
Self-citationAN EPIDEMIOLOGICAL STUDY OF SCLERODERMA IN THE WEST MIDLANDS
SILMAN, A., JANNINI, S., SYMMONS, D., & BACON, P. (1988) · Rheumatology · doi:10.1093/rheumatology/27.4.286 · Cited by 174
Prognostic importance of cardiac arrhythmias in systemic sclerosis
Kostis, J. B., Seibold, J. R., Turkevich, D., Masi, A. T., Grau, R. G., Medsger, T. A., Steen, V. D., Clements, P. J., Szydlo, L., & D’Angelo, W. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90305-1 · Cited by 137
Self-citationMcCarty, G. A., Rice, J. R., Bembe, M., & Barada, F. A. (1983) · Arthritis & Rheumatism · doi:10.1002/art.1780260101 · Cited by 111
Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis
Peters-Golden, M. L., Wise, R. A., Hochberg, M. C., Stevens, M. B., & Wigley, F. M. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90183-9 · Cited by 88
Cited by
Changes in causes of death in systemic sclerosis, 1972–2002
Steen, V. D., & Medsger, T. A. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.066068 · Cited by 1,528
Self-citationTyndall, A. J., Bannert, B., Vonk, M., Airò, P., Cozzi, F., Carreira, P. E., Bancel, D. F., Allanore, Y., Müller-Ladner, U., Distler, O., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.114264 · Cited by 1,443
Mayes, M. D., Lacey, J. V., Beebe‐Dimmer, J., Gillespie, B. W., Cooper, B., Laing, T. J., & Schottenfeld, D. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11073 · Cited by 935
FERRI, C., VALENTINI, G., COZZI, F., SEBASTIANI, M., MICHELASSI, C., LA MONTAGNA, G., BULLO, A., CAZZATO, M., TIRRI, E., STORINO, F., et al. (2002) · Medicine · doi:10.1097/00005792-200203000-00004 · Cited by 764
Severe restrictive lung disease in systemic sclerosis
Steen, V. D., Conte, C., Owens, G. R., & Medsger, T. A. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370903 · Cited by 526
Self-citationElhai, M., Meune, C., Avouac, J., Kahan, A., & Allanore, Y. (2012) · Rheumatology · doi:10.1093/rheumatology/ker269 · Cited by 460
Mortality in systemic sclerosis: An international meta-analysis of individual patient data
Ioannidis, J. P. A., Vlachoyiannopoulos, P. G., Haidich, A.-B., Medsger, T. A., Lucas, M., Michet, C. J., Kuwana, M., Yasuoka, H., van den Hoogen, F., te Boome, L., et al. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.04.031 · Cited by 438
Self-citationSystemic sclerosis-associated interstitial lung disease
Perelas, A., Silver, R. M., Arrossi, A. V., & Highland, K. B. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30480-1 · Cited by 422
Mortality and survival in systemic sclerosis: Systematic review and meta-analysis
Rubio-Rivas, M., Royo, C., Simeón, C. P., Corbella, X., & Fonollosa, V. (2014) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2014.05.010 · Cited by 382
SCUSSEL-LONZETTI, L., JOYAL, F., RAYNAULD, J.-P., ROUSSIN, A., RICH, É., GOULET, J.-R., RAYMOND, Y., & SENÉCAL, J.-L. (2002) · Medicine · doi:10.1097/00005792-200203000-00005 · Cited by 361
VAN DEN HOOGEN, F. H. J., BOERBOOMS, A. M. T., SWAAK, A. J. G., RASKER, J. J., VAN LIER, H. J. J., & VAN DE PUTTE, L. B. A. (1996) · Rheumatology · doi:10.1093/rheumatology/35.4.364 · Cited by 355
“Involvement of heart, lung or kidney, the presence of antitopoisomerase-I autoantibodies and diffuse skin involvement adversely affect outcome [4-6].”
BackgroundDiagnosis and Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease
Vij, R., & Strek, M. E. (2013) · Chest · doi:10.1378/chest.12-0741 · Cited by 333
Reveille, J. D., Fischbach, M., McNearney, T., Friedman, A. W., Aguilar, M. B., Lisse, J., Fritzler, M. J., Ahn, C., & Arnett, F. C. (2001) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2001.20268 · Cited by 277
Gastroesophageal Reflux and Pulmonary Fibrosis in Scleroderma: A Study Using pH-Impedance Monitoring
Savarino, E., Bazzica, M., Zentilin, P., Pohl, D., Parodi, A., Cittadini, G., Negrini, S., Indiveri, F., Tutuian, R., Savarino, V., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200808-1359oc · Cited by 269
Mathai, S. C., Hummers, L. K., Champion, H. C., Wigley, F. M., Zaiman, A., Hassoun, P. M., & Girgis, R. E. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24267 · Cited by 265
Domsic, R. T., Rodriguez-Reyna, T., Lucas, M., Fertig, N., & Medsger, T. A. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.127621 · Cited by 257
Self-citationGender differences in skin: A review of the literature
Dao, H., & Kazin, R. A. (2007) · Gender Medicine · doi:10.1016/s1550-8579(07)80061-1 · Cited by 199
Gastrointestinal complications: the most frequent internal complications of systemic sclerosis
Forbes, A., & Marie, I. (2009) · Rheumatology · doi:10.1093/rheumatology/ken485 · Cited by 162
van Lankveld, W. G. J. M., Vonk, M. C., Teunissen, H., & van den Hoogen, F. H. J. (2007) · Rheumatology · doi:10.1093/rheumatology/kem008 · Cited by 93
Metadata
- Authors
- Altman, R. D., Medsger, T. A., Bloch, D. A., & Michel, B. A.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1991-04
- Volume
- 34
- Issue
- 4
- Pages
- 403-413
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2132986338
- Cited by
- 298
- References
- 13
- FWCI
- 6.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.